Hong Kong Healthtech Stock News

China Resources Gas Group (SEHK:1193) has entered into a new framework agreement for energy supply transactions, covering metering, internal control measures, and oversight of connected transactions, with the aim of broadening integrated energy services and expanding its customer base. See our latest analysis for China Resources Gas Group. At a share price of HK$21.78, China Resources Gas Group has seen a 90 day share price return of 6.87%, but the 1 year total shareholder return of 17.14%...

CNOOC (SEHK:883) has reported first oil from the Buzios6 Project in Brazil’s pre salt Buzios field, a large deep water development that lifts the oilfield’s installed capacity to 1.15 million barrels per day. See our latest analysis for CNOOC. Despite the Buzios6 milestone and recent board changes in late December, CNOOC’s HK$20.94 share price sits after a mixed patch, with a 1 day share price return of 1.26% but a 7 day share price return decline of 4.21%, while the 90 day share price return...

MMG (SEHK:1208) has moved ahead with a major expansion of its Khoemacau Copper Mine in Botswana, committing about US$900 million to increase output capacity and target lower operating costs. See our latest analysis for MMG. That expansion decision comes after a strong run in the stock, with a 30 day share price return of 11.71% and a 90 day share price return of 31.69%, alongside a very large 1 year total shareholder return that points to momentum still building rather than fading. If MMG’s...

Ascentage Pharma Group International (SEHK:6855) has drawn fresh attention after announcing that its BTK-targeted protein degrader APG-3288 received U.S. FDA IND clearance, allowing a global Phase I trial in relapsed or refractory B-cell malignancies. See our latest analysis for Ascentage Pharma Group International. The FDA IND clearance for APG-3288 comes as Ascentage Pharma’s share price sits at HK$54.95, with a 1-day share price return of 1.20% and a 7-day share price return of 7.96%,...

Hansoh Pharmaceutical Group (SEHK:3692) has just received Chinese NMPA approval to expand lung cancer drug Ameile’s use as a first line option in combination therapy for specific EGFR mutated NSCLC patients. See our latest analysis for Hansoh Pharmaceutical Group. The Ameile update comes after a reshuffle of Hansoh Pharmaceutical Group’s board and committees in late December 2025. The latest 1-day share price return of 2.11% at HK$41.6 sits within a year-to-date share price return of 14.16%...

Sino Biopharmaceutical (SEHK:1177) has just reported two key clinical milestones, including first patient enrollment in a Phase III trial for IPF drug candidate TDI01 and positive Phase II data for psoriasis treatment TQH3906. See our latest analysis for Sino Biopharmaceutical. The latest clinical updates arrive after a mixed year for Sino Biopharmaceutical’s shares. The stock has a 7.39% year-to-date share price return at HK$6.83, a 12.44% decline over 90 days, and a very large 1-year total...

Why Dekon Food and Agriculture Group’s Latest Sales Update Matters Dekon Food and Agriculture Group (SEHK:2419) has drawn attention after reporting unaudited December 2025 sales, including 1,109.68 thousand heads of pigs sold and RMB1,663.89 million in revenue, alongside a month on month increase in average hog prices. See our latest analysis for Dekon Food and Agriculture Group. Investors appear to be weighing Dekon Food and Agriculture Group’s strong December sales update against recent...

In December 2025, PCCW Interactive Media Holdings Limited, a subsidiary of PCCW, entered into a Branding and Marketing Arrangements Framework Agreement with FWD Life Insurance covering 1 January 2026 to 31 December 2028, under which PCCW Group (including the HKT Group) will provide branding, spokesperson and marketing services charged at market-referenced rates. The agreement is grounded in arm’s length annual caps informed by historical IFRS-recognised service revenues of about US$6.60...

Galaxy Entertainment Group has announced it will pay a discretionary bonus equivalent to one month of salary to eligible employees on 9 February 2026, covering around 97% of its workforce at senior manager grade or below ahead of the Chinese New Year holiday. This move, the first such bonus announcement among Macau’s six gaming concessionaires for work completed in 2025, highlights management’s focus on staff morale and retention in a highly competitive labour market. We’ll now examine how...

DPC Dash (SEHK:1405), the exclusive Domino’s Pizza franchisee in China, hit its full year store opening target with 1,315 outlets across 60 cities and loyalty membership reaching 35.6 million, highlighting recent operational momentum. See our latest analysis for DPC Dash. Despite the recent operational progress, the share price has been under pressure, with a 30 day share price return of an 8.43% decline and a 90 day share price return of an 18.92% decline, while the 1 year total shareholder...

With a price-to-earnings (or "P/E") ratio of 5x COSCO SHIPPING Holdings Co., Ltd. ( HKG:1919 ) may be sending very...

Investor focus has sharpened on Xiaomi (SEHK:1810) after the company repurchased 3.9 million Type B shares on January 6, 2026, together with fresh attention from a major global investment bank. See our latest analysis for Xiaomi. The recent buyback comes after a tough few months for the share price, with a 90 day share price return of a 27.34% decline and a 30 day share price return of a 9.48% decline. However, the 3 year total shareholder return of 216.22% and 1 year total shareholder return...

Key Insights Significant insider control over SAINT BELLA implies vested interests in company growth A total of 3...

Key Insights Shenghui Cleanness Group Holdings' significant insider ownership suggests inherent interests in company's...

Key Insights Significant insider control over Logory Logistics Technology implies vested interests in company growth...

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

AInnovation Technology Group Co., Ltd ( HKG:2121 ) insiders who purchased shares in the last 12 months were richly...

With a median price-to-sales (or "P/S") ratio of close to 0.7x in the Real Estate industry in Hong Kong, you could be...

When close to half the companies in Hong Kong have price-to-earnings ratios (or "P/E's") above 13x, you may consider...

Key Insights Significant insider control over Mabpharm implies vested interests in company growth A total of 2...

The last three months have been tough on Viva Biotech Holdings ( HKG:1873 ) shareholders, who have seen the share price...

It is hard to get excited after looking at AsiaInfo Technologies' (HKG:1675) recent performance, when its stock has...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Flydoo Technology Holding Limited's ( HKG:8069 ) price-to-sales (or "P/S") ratio of 0.1x may look like a pretty...